01 CENTRIENT PHARMACEUTICALS INDIA PRIVATE LIMITED (1)
02 Amoli Organics (A Division of Umedica Laboratories Pvt.Ltd.) (1)
03 Arch Pharmalabs Limited (1)
04 Biocon Limited (2)
05 Cadila Pharmaceuticals Limited (1)
06 Changzhou Pharmaceutical Factory (1)
07 Chromo Laboratories India Private Limited (1)
08 Hetero Drugs Limited (1)
09 Hetero Labs Limited (1)
10 Jubilant Pharmova Limited (1)
11 MSN Life Sciences Private Limited (1)
12 MSN Pharmachem Private Limited (3)
13 MYLAN LABORATORIES LIMITED (1)
14 PURE AND CURE HEALTHCARE PRIVATE LIMITED (1)
15 Professional Compounding Centers of America dba PCCA (1)
16 Teva API India Private Limited (1)
17 Upjohn Manufacturing Ireland Unlimited Company (1)
18 ZHEJIANG LEPU PHARMACEUTICAL CO., LTD. (1)
01 ATORVASTATIN CALCIUM (3)
02 ATORVASTATIN CALCIUM TRIHYDRATE (2)
03 Atorvastatin (1)
04 Atorvastatin Calcium (7)
05 Atorvastatin Calcium Amorphous (1)
06 Atorvastatin Calcium Form-I (1)
07 Atorvastatin Calcium Trihydrate (2)
08 Atorvastatin calcium (1)
09 Atorvastatin calcium crystalline (1)
10 atorvastatin calcium (1)
11 atorvastatin calcium amorphous (1)
01 China (2)
02 India (12)
03 Israel (1)
04 Netherlands (1)
05 U.S.A (2)
06 United Kingdom (1)
07 Blank (2)
12
PharmaCompass offers a list of Atorvastatin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Atorvastatin manufacturer or Atorvastatin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Atorvastatin manufacturer or Atorvastatin supplier.
PharmaCompass also assists you with knowing the Atorvastatin API Price utilized in the formulation of products. Atorvastatin API Price is not always fixed or binding as the Atorvastatin Price is obtained through a variety of data sources. The Atorvastatin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A atorvastatin calcium anhydrous manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of atorvastatin calcium anhydrous, including repackagers and relabelers. The FDA regulates atorvastatin calcium anhydrous manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. atorvastatin calcium anhydrous API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of atorvastatin calcium anhydrous manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A atorvastatin calcium anhydrous supplier is an individual or a company that provides atorvastatin calcium anhydrous active pharmaceutical ingredient (API) or atorvastatin calcium anhydrous finished formulations upon request. The atorvastatin calcium anhydrous suppliers may include atorvastatin calcium anhydrous API manufacturers, exporters, distributors and traders.
click here to find a list of atorvastatin calcium anhydrous suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing atorvastatin calcium anhydrous as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for atorvastatin calcium anhydrous API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture atorvastatin calcium anhydrous as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain atorvastatin calcium anhydrous and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a atorvastatin calcium anhydrous NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of atorvastatin calcium anhydrous suppliers with NDC on PharmaCompass.
We have 14 companies offering atorvastatin calcium anhydrous
Get in contact with the supplier of your choice: